Literature DB >> 27683909

Genetic Restoration of Plasma ApoE Improves Cognition and Partially Restores Synaptic Defects in ApoE-Deficient Mice.

Courtney Lane-Donovan1, Wen Mai Wong2, Murat S Durakoglugil2, Catherine R Wasser2, Shan Jiang2, Xunde Xian2, Joachim Herz3.   

Abstract

UNLABELLED: Alzheimer's disease (AD) is the most common form of dementia in individuals over the age of 65 years. The most prevalent genetic risk factor for AD is the ε4 allele of apolipoprotein E (ApoE4), and novel AD treatments that target ApoE are being considered. One unresolved question in ApoE biology is whether ApoE is necessary for healthy brain function. ApoE knock-out (KO) mice have synaptic loss and cognitive dysfunction; however, these findings are complicated by the fact that ApoE knock-out mice have highly elevated plasma lipid levels, which may independently affect brain function. To bypass the effect of ApoE loss on plasma lipids, we generated a novel mouse model that expresses ApoE normally in peripheral tissues, but has severely reduced ApoE in the brain, allowing us to study brain ApoE loss in the context of a normal plasma lipid profile. We found that these brain ApoE knock-out (bEKO) mice had synaptic loss and dysfunction similar to that of ApoE KO mice; however, the bEKO mice did not have the learning and memory impairment observed in ApoE KO mice. Moreover, we found that the memory deficit in the ApoE KO mice was specific to female mice and was fully rescued in female bEKO mice. Furthermore, while the AMPA/NMDA ratio was reduced in ApoE KO mice, it was unchanged in bEKO mice compared with controls. These findings suggest that plasma lipid levels can influence cognition and synaptic function independent of ApoE expression in the brain. SIGNIFICANCE STATEMENT: One proposed treatment strategy for Alzheimer's disease (AD) is the reduction of ApoE, whose ε4 isoform is the most common genetic risk factor for the disease. A major concern of this strategy is that an animal model of ApoE deficiency, the ApoE knock-out (KO) mouse, has reduced synapses and cognitive impairment; however, these mice also develop dyslipidemia and severe atherosclerosis. Here, we have shown that genetic restoration of plasma ApoE to wild-type levels normalizes plasma lipids in ApoE KO mice. While this does not rescue synaptic loss, it does completely restore learning and memory in the mice, suggesting that both CNS and plasma ApoE are independent parameters that affect brain health.
Copyright © 2016 the authors 0270-6474/16/3610141-10$15.00/0.

Entities:  

Keywords:  Alzheimer's; ApoE; ApoE4; cognition; dementia

Mesh:

Substances:

Year:  2016        PMID: 27683909      PMCID: PMC5039258          DOI: 10.1523/JNEUROSCI.1054-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

1.  Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice.

Authors:  H Hamanaka; Y Katoh-Fukui; K Suzuki; M Kobayashi; R Suzuki; Y Motegi; Y Nakahara; A Takeshita; M Kawai; K Ishiguro; M Yokoyama; S C Fujita
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

Review 2.  More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration.

Authors:  Courtney Lane-Donovan; Gary T Philips; Joachim Herz
Journal:  Neuron       Date:  2014-08-20       Impact factor: 17.173

3.  Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro.

Authors:  D J Stone; I Rozovsky; T E Morgan; C P Anderson; H Hajian; C E Finch
Journal:  Exp Neurol       Date:  1997-02       Impact factor: 5.330

4.  Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE.

Authors:  E Masliah; W Samuel; I Veinbergs; M Mallory; M Mante; T Saitoh
Journal:  Brain Res       Date:  1997-03-21       Impact factor: 3.252

5.  Vitamin E supplementation prevents spatial learning deficits and dendritic alterations in aged apolipoprotein E-deficient mice.

Authors:  I Veinbergs; M Mallory; Y Sagara; E Masliah
Journal:  Eur J Neurosci       Date:  2000-12       Impact factor: 3.386

6.  Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice.

Authors:  G Caligiuri; A Nicoletti; X Zhou; I Törnberg; G K Hansson
Journal:  Atherosclerosis       Date:  1999-08       Impact factor: 5.162

7.  Loss of apolipoprotein E receptor LR11 in Alzheimer disease.

Authors:  Clemens R Scherzer; Katrin Offe; Marla Gearing; Howard D Rees; Guofu Fang; Craig J Heilman; Chica Schaller; Hideaki Bujo; Allan I Levey; James J Lah
Journal:  Arch Neurol       Date:  2004-08

8.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

Authors:  A S Plump; J D Smith; T Hayek; K Aalto-Setälä; A Walsh; J G Verstuyft; E M Rubin; J L Breslow
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

9.  Sex modifies the APOE-related risk of developing Alzheimer disease.

Authors:  Andre Altmann; Lu Tian; Victor W Henderson; Michael D Greicius
Journal:  Ann Neurol       Date:  2014-04-14       Impact factor: 10.422

10.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

Authors:  S H Zhang; R L Reddick; J A Piedrahita; N Maeda
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

View more
  34 in total

Review 1.  Peripheral versus central nervous system APOE in Alzheimer's disease: Interplay across the blood-brain barrier.

Authors:  Dustin Chernick; Stephanie Ortiz-Valle; Angela Jeong; Wenhui Qu; Ling Li
Journal:  Neurosci Lett       Date:  2019-06-07       Impact factor: 3.046

2.  Apolipoprotein E4 Impairs Neuronal Insulin Signaling by Trapping Insulin Receptor in the Endosomes.

Authors:  Na Zhao; Chia-Chen Liu; Alexandra J Van Ingelgom; Yuka A Martens; Cynthia Linares; Joshua A Knight; Meghan M Painter; Patrick M Sullivan; Guojun Bu
Journal:  Neuron       Date:  2017-09-27       Impact factor: 17.173

Review 3.  ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease.

Authors:  Courtney Lane-Donovan; Joachim Herz
Journal:  Trends Endocrinol Metab       Date:  2017-01-02       Impact factor: 12.015

4.  Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function.

Authors:  Chia-Chen Liu; Jing Zhao; Yuan Fu; Yasuteru Inoue; Yingxue Ren; Yuanxin Chen; Sydney V Doss; Francis Shue; Suren Jeevaratnam; Ligia Bastea; Na Wang; Yuka A Martens; Wenhui Qiao; Minghui Wang; Na Zhao; Lin Jia; Yu Yamazaki; Akari Yamazaki; Cassandra L Rosenberg; Zhen Wang; Dehui Kong; Zonghua Li; Lindsey A Kuchenbecker; Zachary A Trottier; Lindsey Felton; Justin Rogers; Zachary S Quicksall; Cynthia Linares; Joshua Knight; Yixing Chen; Aishe Kurti; Takahisa Kanekiyo; John D Fryer; Yan W Asmann; Peter Storz; Xusheng Wang; Junmin Peng; Bin Zhang; Betty Y S Kim; Guojun Bu
Journal:  Nat Neurosci       Date:  2022-08-01       Impact factor: 28.771

5.  The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis.

Authors:  Sonia Sanz Muñoz; Hongyun Li; Kalani Ruberu; Qian Chu; Alan Saghatelian; Lezanne Ooi; Brett Garner
Journal:  J Biol Chem       Date:  2018-02-02       Impact factor: 5.157

6.  Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model.

Authors:  Alexandra Litvinchuk; Tien-Phat V Huynh; Yang Shi; Rosemary J Jackson; Mary B Finn; Melissa Manis; Caroline M Francis; Ainsley C Tran; Patrick M Sullivan; Jason D Ulrich; Bradley T Hyman; Tracy Cole; David M Holtzman
Journal:  Ann Neurol       Date:  2021-02-24       Impact factor: 10.422

7.  Association of lipoproteins and thyroid hormones with cognitive dysfunction in patients with systemic lupus erythematosus.

Authors:  Li Lu; Wei Kong; Kangxing Zhou; Jinglei Chen; Yayi Hou; Huan Dou; Jun Liang
Journal:  BMC Rheumatol       Date:  2021-06-09

8.  The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer's Disease: Exploring Interactions With Sex.

Authors:  Ying Liu; Jing-Hui Song; Wei Xu; Xiao-He Hou; Jie-Qiong Li; Jin-Tai Yu; Lan Tan; Song Chi
Journal:  Front Neurosci       Date:  2021-03-03       Impact factor: 4.677

Review 9.  Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.

Authors:  Yu Yamazaki; Na Zhao; Thomas R Caulfield; Chia-Chen Liu; Guojun Bu
Journal:  Nat Rev Neurol       Date:  2019-07-31       Impact factor: 44.711

Review 10.  Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.

Authors:  Na Zhao; Chia-Chen Liu; Wenhui Qiao; Guojun Bu
Journal:  Biol Psychiatry       Date:  2017-03-14       Impact factor: 12.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.